Funding: The analyses were funded by Boehringer Ingelheim. Access to data from the Optimum Patient Care Research Database was co-funded by Research in Real Life Ltd. The funder, Boehringer Ingelheim, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rafael Mares is employed by Research in Real Life Ltd., which provided support in the form of salary for author RM but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section. Acknowledgments The authors wish to thank Vicky Thomas, Elizabeth Gardener, Rosie McDonald, Simon Yau and J.B. Soriano fo...
OBJECTIVEdTo identify if there is a dose-dependent risk of diabetes complications in patients treate...
SummaryBackgroundA recent case-controlled study reported an increased risk of diabetes mellitus in p...
SummaryBackgroundCorticosteroid-induced hyperglycemia is a known adverse effect. There are no studie...
BackgroundManagement guidelines for chronic obstructive pulmonary disease (COPD) recommend that inha...
Background Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inh...
Background Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inh...
Introduction: Type 2 diabetes mellitus (T2DM) is a common comorbidity of COPD. ICS treatment may be ...
ACKNOWLEDGEMENTS We thank Derek Skinner for his contributions to the data acquisition and handling. ...
OBJECTIVE: To identify if there is a dose-dependent risk of diabetes complications in patients treat...
BACKGROUND: Inhaled corticosteroids (ICS), especially when prescribed in combination with long-actin...
Background:Little is known about the association between COPD and diabetes control parameters.Aims:T...
Some studies suggest an association between onset and/or poor control of type 2 diabetes mellitus an...
OBJECTIVE The objective of this selective EBM review is to determine whether or not inhaled corticos...
Background: Little is known about the association between COPD and diabetes control parameters. Aim...
Altres ajuts: Boehringer IngelheimAltres ajuts: European Respiratory Society (ERS)Inhaled corticoste...
OBJECTIVEdTo identify if there is a dose-dependent risk of diabetes complications in patients treate...
SummaryBackgroundA recent case-controlled study reported an increased risk of diabetes mellitus in p...
SummaryBackgroundCorticosteroid-induced hyperglycemia is a known adverse effect. There are no studie...
BackgroundManagement guidelines for chronic obstructive pulmonary disease (COPD) recommend that inha...
Background Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inh...
Background Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inh...
Introduction: Type 2 diabetes mellitus (T2DM) is a common comorbidity of COPD. ICS treatment may be ...
ACKNOWLEDGEMENTS We thank Derek Skinner for his contributions to the data acquisition and handling. ...
OBJECTIVE: To identify if there is a dose-dependent risk of diabetes complications in patients treat...
BACKGROUND: Inhaled corticosteroids (ICS), especially when prescribed in combination with long-actin...
Background:Little is known about the association between COPD and diabetes control parameters.Aims:T...
Some studies suggest an association between onset and/or poor control of type 2 diabetes mellitus an...
OBJECTIVE The objective of this selective EBM review is to determine whether or not inhaled corticos...
Background: Little is known about the association between COPD and diabetes control parameters. Aim...
Altres ajuts: Boehringer IngelheimAltres ajuts: European Respiratory Society (ERS)Inhaled corticoste...
OBJECTIVEdTo identify if there is a dose-dependent risk of diabetes complications in patients treate...
SummaryBackgroundA recent case-controlled study reported an increased risk of diabetes mellitus in p...
SummaryBackgroundCorticosteroid-induced hyperglycemia is a known adverse effect. There are no studie...